Psoriasis Treatments in Older Adults: Navigating Safety Concerns

For older adults with psoriasis or psoriatic arthritis, finding effective and safe treatments presents unique challenges that haven't been fully explored in clinical research. A recent analysis published in the Journal of Investigative Dermatology sheds light on this important topic.

Systemic therapies that treat psoriasis and psoriatic arthritis (PsA) can potentially cause serious adverse events (SAEs), with older adults facing particular vulnerability, according to the research. While these medications provide relief for many patients, understanding their safety profiles specifically in older populations has been a significant gap in our knowledge.

The study notes that a network meta-analysis of clinical trials comparing different systemic therapies for psoriasis didn't identify meaningful differences in SAE risk between medication classes. However, the researchers point out critical limitations in this evidence base — most studies featured short-term trials with low SAE rates, and importantly, clinical trials for psoriasis largely exclude older adults and include relatively few people with psoriatic arthritis.

Age-Related Treatment Considerations

This research highlights a persistent challenge in dermatological care: the evidence we rely on often doesn't adequately represent the very populations most vulnerable to treatment complications. Older adults with psoriatic disease face unique physiological considerations including potential drug interactions, reduced organ function, and comorbidities that might affect treatment response and safety.

For the albinism community, this research serves as an important reminder about the need for age-specific research across all dermatological conditions. While the study focuses on psoriasis, the principle applies broadly — treatment approaches must be tailored to life stages and individual needs.

As medicine moves toward more personalized care approaches, this research underscores the importance of developing safety guidelines that account for age, existing health conditions, and other individual factors to ensure treatments remain both effective and safe across the lifespan.